Exogenous nitric oxide decreases brain vascular inflammation, leakage and venular resistance during Plasmodium berghei ANKA infection in mice

Journal of Neuroinflammation

Volumn 8, Issue , 2011, Pages

  Zanini, Graziela M ^a,b   Cabrales, Pedro ^a,c   Barkho, Wisam ^a   Frangos, John A ^a   Carvalho, Leonardo J M ^a  

^a LA JOLLA BIOENGINEERING INSTITUTE   (United States)

^b Funda??o Oswaldo Cruz   (Brazil)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIBODY; CD45 ANTIGEN; CELL ADHESION MOLECULE; DIPROPYLENETRIAMINE NONOATE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FIBRINOGEN RECEPTOR; FLUORESCEIN ISOTHIOCYANATE; INTERCELLULAR ADHESION MOLECULE 1; NITRIC OXIDE; NITRIC OXIDE DONOR; PADGEM PROTEIN; PENTETIC ACID; SODIUM CHLORIDE; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; ALKENE; DIPROPYLENETRIAMINE-NONOATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BLOOD VESSEL OCCLUSION; BRAIN BLOOD FLOW; BRAIN BLOOD VESSEL; BRAIN HEMORRHAGE; BRAIN MALARIA; BRAIN TISSUE; BRAIN VASCULITIS; C57BL 6 MOUSE; CONTROLLED STUDY; DRUG MECHANISM; ENCEPHALITIS; GENETIC STRAIN; LEUKOCYTE ADHERENCE; MICROSCOPY; MOUSE; NONHUMAN; PLASMODIUM BERGHEI INFECTION; PROTEIN EXPRESSION; THROMBOCYTE ADHESION; VEIN RESISTANCE; WESTERN BLOTTING; ANIMAL; BRAIN; BRAIN CIRCULATION; C57BL MOUSE; CYTOLOGY; DRUG EFFECT; HISTOLOGY; LEUKOCYTE; MALARIA; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; PATHOPHYSIOLOGY; PLASMODIUM BERGHEI; THROMBOCYTE ADHESIVENESS; VASCULAR RESISTANCE; VENULE;

ALKENES; ANIMALS; BRAIN; CEREBROVASCULAR CIRCULATION; E-SELECTIN; ENCEPHALITIS; INTERCELLULAR ADHESION MOLECULE-1; LEUKOCYTES; MALARIA, CEREBRAL; MICE; MICE, INBRED C57BL; NITRIC OXIDE; P-SELECTIN; PLASMODIUM BERGHEI; PLATELET ADHESIVENESS; VASCULAR CELL ADHESION MOLECULE-1; VASCULAR RESISTANCE; VENULES;

EID: 79957967935     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-8-66     Document Type: Article

References (46)

1. Rowe AK, Rowe SY, Snow RW, Korenromp EL, Schellenberg JR, Stein C, Nahlen BL, Bryce J, Black RE, Steketee RW. The burden of malaria mortality among African children in the year 2000. Int J Epidemiol 2006, 35:691-704. 10.1093/ije/dyl027, 16507643.
2. Grau GE, Piguet PF, Engers HD, Louis JA, Vassalli P, Lambert PH. L3T4+ T lymphocytes play a major role in the pathogenesis of murine cerebral malaria. J Immunol 1986, 137:2348-2354.
3. Grau GE, Fajardo LF, Piguet PF, Allet B, Lambert PH, Vassalli P. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science 1987, 237:1210-1212. 10.1126/science.3306918, 3306918.
4. Grau GE, Heremans H, Piguet PF, Pointaire P, Lambert PH, Billiau A, Vassalli P. Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor. Proc Natl Acad Sci USA 1989, 86:5572-5574. 10.1073/pnas.86.14.5572, 297664, 2501793.
5. Engwerda CR, Mynott TL, Sawhney S, De Souza JB, Bickle QD, Kaye PM. Locally up-regulated lymphotoxin alpha, not systemic tumor necrosis factor alpha, is the principle mediator of murine cerebral malaria. J Exp Med 2002, 195:1371-1377. 10.1084/jem.20020128, 2193758, 12021316.
6. Belnoue E, Kayibanda M, Vigario AM, Deschemin JC, van Rooijen N, Viguier M, Snounou G, Rénia L. On the pathogenic role of brain-sequestered alphabeta CD8+ T cells in experimental cerebral malaria. J Immunol 2002, 169:6369-6375.
7. Yañez DM, Manning DD, Cooley AJ, Weidanz WP, van der Heyde HC. Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria. J Immunol 1996, 157:1620-1624.
8. van der Heyde HC, Nolan J, Combes V, Gramaglia I, Grau GE. A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. Trends Parasitol 2006, 22:503-508. 10.1016/j.pt.2006.09.002, 16979941.
9. Gramaglia I, Sobolewski P, Meays D, Contreras R, Nolan JP, Frangos JA, Intaglietta M, van der Heyde HC. Low nitric oxide bioavailability contributes to the genesis of experimental cerebral malaria. Nat Med 2006, 12:1417-1422.
10. Machado FS, Desruisseaux MS, Nagajyothi, Kennan RP, Hetherington HP, Wittner M, Weiss LM, Lee SC, Scherer PE, Tsuji M, Tanowitz HB. Endothelin in a murine model of cerebral malaria. Exp Biol Med 2006, 231:1176-1181.
11. Desruisseaux MS, Machado FS, Weiss LM, Tanowitz HB, Golightly LM. Cerebral malaria: a vasculopathy. Am J Pathol 2010, 176:1075-1078. 10.2353/ajpath.2010.091090, 2832128, 20093501.
12. Bauer PR, Van Der Heyde HC, Sun G, Specian RD, Granger DN. Regulation of endothelial cell adhesion molecule expression in an experimental model of cerebral malaria. Microcirculation 2002, 9:463-470.
13. Cabrales P, Zanini GM, Meays D, Frangos JA, Carvalho LJM. Murine Cerebral malaria is associated with a vasospasm-like microcirculatory dysfunction and survival upon rescue treatment is markedly increased by nimodipine. Am J Pathol 2010, 176:1306-1315. 10.2353/ajpath.2010.090691, 2832151, 20110412.
14. Nitcheu J, Bonduelle O, Combadiere C, Tefit M, Seilhean D, Mazier D, Combadiere B. Perforin-dependent brain-infiltrating cytotoxic CD8+ T lymphocytes mediate experimental cerebral malaria pathogenesis. J Immunol 2003, 170:2221-2228.
15. Potter S, Chan-Ling T, Ball HJ, Mansour H, Mitchell A, Maluish L, Hunt NH. Perforin mediated apoptosis of cerebral microvascular endothelial cells during experimental cerebral malaria. Int J Parasitol 2006, 36:485-496. 10.1016/j.ijpara.2005.12.005, 16500656.
16. Lackner P, Burger C, Pfaller K, Heussler V, Helbok R, Morandell M, Broessner G, Tannich E, Schmutzhard E, Beer R. Apoptosis in experimental cerebral malaria: spatial profile of cleaved caspase-3 and ultrastructural alterations in different disease stages. Neuropathol Appl Neurobiol 2007, 33:560-571.
17. Carvalho LJM, Lenzi HL, Pelajo-Machado M, Oliveira DN, Daniel-Ribeiro CT, Ferreira-da-Cruz MF. Plasmodium berghei: cerebral malaria in CBA mice is not clearly related to plasma TNF levels or intensity of histopathological changes. Exp Parasitol 2000, 95:1-7. 10.1006/expr.2000.4508, 10864512.
18. Cabrales P, Zanini GM, Meays D, Frangos JA, Carvalho LJM. Nitric oxide protection against murine cerebral malaria is associated with improved cerebral microcirculatory physiology. J Infect Dis 2011, 203:1454-1463. 10.1093/infdis/jir058, 21415018.
19. Davenpeck KL, Gauthier TW, Lefer AM. Inhibition of endothelial-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation. Gastroenterology 1994, 107:1050-1058.
20. Luvarà G, Pueyo ME, Philippe M, Mandet C, Savoie F, Henrion D, Michel JB. Chronic blockade of NO synthase activity induces a proinflammatory phenotype in the arterial wall: prevention by angiotensin II antagonism. Arterioscler Thromb Vasc Biol 1998, 18:1408-1416.
21. Scalia R, Appel JZ, Lefer AM. Leukocyte-endothelium interaction during the early stages of hypercholesterolemia in the rabbit: role of P-selectin, ICAM-1, and VCAM-1. Arterioscler Thromb Vasc Biol 1998, 18:1093-1100.
22. Schäfer A, Bauersachs J. Endothelial dysfunction, impaired endogenous platelet inhibition and platelet activation in diabetes and atherosclerosis. Curr Vasc Pharmacol 2008, 6:52-60. 10.2174/157016108783331295, 18220940.
23. Hiratsuka M, Katayama T, Uematsu K, Kiyomura M, Ito M. In vivo visualization of nitric oxide and interactions among platelets, leukocytes, and endothelium following hemorrhagic shock and reperfusion. Inflamm Res 2009, 58:463-471. 10.1007/s00011-009-0011-0, 19262990.
24. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991, 88:4651-4655. 10.1073/pnas.88.11.4651, 51723, 1675786.
25. Lefer DJ, Jones SP, Girod WG, Baines A, Grisham MB, Cockrell AS, Huang PL, Scalia R. Leukocyte-endothelial cell interactions in nitric oxide synthase-deficient mice. Am J Physiol 1999, 276:H1943-1950.
26. Zampolli A, Basta G, Lazzerini G, Feelisch M, De Caterina R. Inhibition of endothelial cell activation by nitric oxide donors. J Pharmacol Exp Ther 2000, 295:818-823.
27. Conran N, Franco-Penteado CF, Costa FF. Newer aspects of the pathophysiology of sickle cell disease vaso-occlusion. Hemoglobin 2009, 33:1-16. 10.1080/03630260802625709, 19205968.
28. Cabrales P, Carvalho LJM. Intravital microscopy of the mouse brain microcirculation using a closed cranial window. J Vis Exp 2011, 45:2184.
29. Thumwood CM, Hunt NH, Clark IA, Cowden WB. Breakdown of the blood-brain barrier in murine cerebral malaria. Parasitology 1988, 96:579-589. 10.1017/S0031182000080203, 2457201.
30. de Souza JB, Hafalla JC, Riley EM, Couper KN. Cerebral malaria: why experimental murine models are required to understand the pathogenesis of disease. Parasitology 2010, 137:755-772. 10.1017/S0031182009991715, 20028608.
31. Silamut K, Phu NH, Whitty C, Turner GD, Louwrier K, Mai NT, Simpson JA, Hien TT, White NJ. A quantitative analysis of the microvascular sequestration of malaria parasites in the human brain. Am J Pathol 1999, 155:395-410. 10.1016/S0002-9440(10)65136-X, 1866852, 10433933.
32. Turner GD, Morrison H, Jones M, Davis TM, Looareesuwan S, Buley ID, Gatter KC, Newbold CI, Pukritayakamee S, Nagachinta B, White NJ, Berendt AR. An immunohistochemical study of the pathology of fatal malaria. Evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration. Am J Pathol 1994, 145:1057-1069. 1887431, 7526692.
33. Armah H, Wired EK, Dodoo AK, Adjei AA, Tettey Y, Gyasi R. Cytokines and adhesion molecules expression in the brain in human cerebral malaria. Int J Environ Res Public Health 2005, 2:123-131. 10.3390/ijerph2005010123, 16705810.
34. Grau GE, Pointaire P, Piguet PF, Vesin C, Rosen H, Stamenkovic I, Takei F, Vassalli P. Late administration of monoclonal antibody to leukocyte function-antigen 1 abrogates incipient murine cerebral malaria. Eur J Immunol 1991, 21:2265-2267. 10.1002/eji.1830210939, 1679717.
35. Ma N, Hunt NH, Madigan MC, Chan-Ling T. Correlation between enhanced vascular permeability, up-regulation of cellular adhesion molecules and monocyte adhesion to the endothelium in the retina during the development of fatal murine cerebral malaria. Am J Pathol 1996, 149:1745-1762. 1865264, 8909263.
36. Chang WL, Li J, Sun G, Chen HL, Specian RD, Berney SM, Granger DN, van der Heyde HC. P-selectin contributes to severe experimental malaria but is not required for leukocyte adhesion to brain microvasculature. Infect Immun 2003, 71:1911-1918. 10.1128/IAI.71.4.1911-1918.2003, 152027, 12654808.
37. Favre N, Da Laperousaz C, Ryffel B, Weiss NA, Imhof BA, Rudin W, Lucas R, Piguet PF. Role of ICAM-1 (CD54) in the development of murine cerebral malaria. Microbes Infect 1999, 1:961-968. 10.1016/S1286-4579(99)80513-9, 10617927.
38. Li J, Chang WL, Sun G, Chen HL, Specian RD, Berney SM, Kimpel D, Granger DN, van der Heyde HC. Intercellular adhesion molecule 1 is important for the development of severe experimental malaria but is not required for leukocyte adhesion in the brain. J Investig Med 2003, 51:128-140.
39. Vachharajani V, Vital S, Russell J, Scott LK, Granger DN. Glucocorticoids inhibit the cerebral microvascular dysfunction associated with sepsis in obese mice. Microcirculation 2006, 13:477-487. 10.1080/10739680600777599, 16864414.
40. De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TB, Gimbrone MA, Shin WS, Liao JK. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 1995, 96:60-68. 10.1172/JCI118074, 185173, 7542286.
41. Carvalho LJ, Ferreira-da-Cruz MF, Daniel-Ribeiro CT, Pelajo-Machado M, Lenzi HL. Germinal center architecture disturbance during Plasmodium berghei ANKA infection in CBA mice. Malar J 2007, 6:59. 10.1186/1475-2875-6-59, 1890294, 17506896.
42. Sun G, Chang WL, Li J, Berney SM, Kimpel D, van der Heyde HC. Inhibition of platelet adherence to brain microvasculature protects against severe Plasmodium berghei malaria. Infect Immun 2003, 71:6553-6561. 10.1128/IAI.71.11.6553-6561.2003, 219602, 14573677.
43. Santhanam AV, Smith LA, Nath KA, Katusic ZS. In vivo stimulatory effect of erythropoietin on endothelial nitric oxide synthase in cerebral arteries. Am J Physiol Heart Circ Physiol 2006, 291:H781-786. 10.1152/ajpheart.00045.2006, 16565320.
44. Toba H, Nakashima K, Oshima Y, Kojima Y, Tojo C, Nakano A, Wang J, Kobara M, Nakata T. Erythropoietin prevents vascular inflammation and oxidative stress in subtotal nephrectomized rat aorta beyond haematopoiesis. Clin Exp Pharmacol Physiol 2010, 37:1139-1146. 10.1111/j.1440-1681.2010.05445.x, 20819095.
45. Wiese L, Hempel C, Penkowa M, Kirkby N, Kurtzhals JA. Recombinant human erythropoietin increases survival and reduces neuronal apoptosis in a murine model of cerebral malaria. Malar J 2008, 7:3. 10.1186/1475-2875-7-3, 2257967, 18179698.
46. Kurose I, Kubes P, Wolf R, Anderson DC, Paulson J, Miyasaka M, Granger DN. Inhibition of nitric oxide production. Mechanisms of vascular albumin leakage. Circ Res 1993, 73:164-171.